Package Leaflet: Information for the User
Ebastina Gador 10 mg Oral Disintegrating Tablets EFG
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the package leaflet
Ebastina Gador contains the active substance ebastine. It belongs to a group of medicines called antihistamines.
Ebastina Gador is indicated for the treatment of symptoms of allergic processes such as seasonal or perennial allergic rhinitis, with or without allergic conjunctivitis (such as runny nose, nasal itching, eye itching, tearing, sneezing), chronic urticaria, and allergic dermatitis.
Warnings and precautions
Consult your doctor or pharmacist before taking Ebastina Gador.
If you have an acute allergic emergency, Ebastina Gador takes 1 to 3 hours to develop its effects.
Children
Taking Ebastina Gador with other medicines
Tell your doctor or pharmacist that you are taking, have recently taken, or might take any other medicines.
This is because Ebastina Gador may interfere with the way some medicines work and some of them may affect Ebastina Gador.
Interference with diagnostic tests
Ebastina Gador may interfere with the results of skin allergy tests, so it is recommended not to perform them until 5-7 days have passed since the treatment was discontinued.
Taking Ebastina Gador with food and drinks
You can take oral disintegrating tablets with food or on an empty stomach.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
No effects on psychomotor function have been observed in humans, nor on the ability to drive or use machinery, at the recommended therapeutic doses. However, since the side effects include drowsiness and dizziness, observe your response to treatment before driving or using machinery.
Ebastina Gador oral disintegrating tablets contain aspartame (E-951)
This medicine contains 2.5 mg of aspartame in each tablet.
Aspartame is a source of phenylalanine, which may be harmful in people with phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body cannot eliminate it properly.
Ebastina Gador oral disintegrating tablets contain lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Your doctor will tell you how many oral disintegrating tablets you should take and the duration of your treatment. This will depend on your condition and age. The recommended dose is as follows:
Use in adults and children over 12 years
The recommended dose in adults and children over 12 years is 1 oral disintegrating tablet (10 mg) once a day.
Use in patients with severe liver disease
It is not recommended to exceed the dose of 10 mg per day.
If you think the effect of Ebastina Gador is too strong or too weak, consult your doctor or pharmacist.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
If you take more Ebastina Gador than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
Treatment of poisoning with this medicine consists of gastric lavage and administration of appropriate medication. Carry this package leaflet with you.
If you forget to take Ebastina Gador
Do not take a double dose to make up for forgotten doses. Take the forgotten dose as soon as you remember and then continue taking this medicine with your usual schedule. If it is almost time for your next dose, do not take the forgotten dose, and wait for the next scheduled dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been observed in clinical trials and post-marketing experience:
Rare (>1/10,000 to <1/1,000):
Very rare (<1/10,000):
Frequency not known (cannot be estimated from the available data):
-weight gain
-increased appetite
Do not worry about this list of possible side effects. You may not get any of them. If you experience side effects, talk to your doctor or pharmacist, even if they are not listed in this package leaflet.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's online platform: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
No special storage conditions are required.
Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy. If you are unsure, ask your pharmacist how to dispose of the containers and any unused medicines. This will help protect the environment.
Composition of Ebastina Gador:- The active substance is ebastine. Ebastina Gador oral disintegrating tablets contain 10 mg of ebastine. - The other ingredients (excipients) are: lactose monohydrate, microcrystalline cellulose 101, sodium croscarmellose, aspartame (E-951), magnesium stearate, anhydrous colloidal silica, peppermint flavor.
Appearance of the product and pack contents
Ebastina Gador 10 mg oral disintegrating tablets: white, round oral disintegrating tablets packaged in blisters.
Pack size: 20 oral disintegrating tablets.
Marketing authorization holder and manufacturer:
Marketing authorization holder:
Qualix Pharma S.L.
C/ de la Botánica 137-139
08908 L’Hospitalet de Llobregat
Barcelona
Spain
Manufacturer:
SEID, S.A.
Carretera de Sabadell a Granollers Km 15
08185 Lliçà de Vall – Barcelona
Spain
This medicine is authorized in the EEA Member States with the following names:
Spain | Ebastina Gador 10 mg oral disintegrating tablets EFG |
Portugal | Ebastina Qualitec 10 mg oral disintegrating tablets |
Date of the last revision of this package leaflet: December 2023